PublizoomRiePharm GmbH
Track this competitor Create a free account to be notified when it wins a contract.
- Contracts won
- 1
- Shared contracts
- 1 (multi-supplier framework agreements)
- Period
- 3 July 2026 – 3 July 2026
Its main clients
- DAK-Gesundheit · 1 contract
Where and what
Supplies · 1
Its contracts coming to an end
So many opportunities to take over these contracts when they are re-tendered.
| Planned end | Contract | Current holder | Amount |
|---|---|---|---|
| 1 March 2027 re-tender around October 2026 |
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Erythropoietin ausschließlich Epoetin alfa, ATC B03XA01 für die Zeit 01.03.2025 - 28.02.2027
DAK-Gesundheit |
RiePharm GmbH CC Pharma GmbH Abacus Medicine A/S axicorp Pharma GmbH EMRA-MED Arzneimittel GmbH EurimPharm Arzneimittel GmbH kohlpharma GmbH Hexal AG MEDICE Arzneimittel Pütter GmbH & Co. KG 12 bids received |
€1 |
Contracts won
| Date | Contract | Buyer | Amount |
|---|---|---|---|
| 03/07/2026 | Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Erythropoietin ausschließlich Epoetin alfa, ATC B03XA01 für die Zeit 01.03.2025 - 28.02.2027 | DAK-Gesundheit | €1 shared by 9 |
Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.